Pediatric psychopharmacology for primary care /:
Completely updated and revised, the third edition provides primary care physicians with practice-tested, condition-specific treatment recommendations for various childhood mental disorders. Obtain clear guidance on dosing, monitoring, and potential adverse reactions of psychotropic medications for t...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Itasca, IL :
American Academy of Pediatrics,
[2022]
|
| Ausgabe: | Third edition |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Zusammenfassung: | Completely updated and revised, the third edition provides primary care physicians with practice-tested, condition-specific treatment recommendations for various childhood mental disorders. Obtain clear guidance on dosing, monitoring, and potential adverse reactions of psychotropic medications for treatment of common psychiatric disorders and mental health or behavioral problems in children and adolescents. -- Provided by publisher. |
| Beschreibung: | 1 online resource |
| Bibliographie: | Includes bibliographical references and index |
| ISBN: | 9781610025478 1610025474 |
Internformat
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | ZDB-4-EBA-on1269480406 | ||
| 003 | OCoLC | ||
| 005 | 20241004212047.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 210929t20222022ilu ob 001 0 eng d | ||
| 040 | |a YDX |b eng |e rda |e pn |c YDX |d N$T |d YDX |d TETON |d CUV |d KOS |d OCLCO |d HF9 |d OCLCO |d OCL |d OCLCQ |d CASUM |d USU |d OCLCO |d OCLCL |d OCLCQ | ||
| 019 | |a 1269317143 | ||
| 020 | |a 9781610025478 |q (electronic book) | ||
| 020 | |a 1610025474 |q (electronic book) | ||
| 020 | |z 9781610025461 | ||
| 020 | |z 1610025466 | ||
| 035 | |a (OCoLC)1269480406 |z (OCoLC)1269317143 | ||
| 050 | 4 | |a RJ504.7 |b .R53 2022eb | |
| 060 | 4 | |a WS 350.33 | |
| 082 | 7 | |a 615.7/8083 |2 23 | |
| 049 | |a MAIN | ||
| 100 | 1 | |a Riddle, Mark A., |e author. |0 http://id.loc.gov/authorities/names/no2009132554 | |
| 245 | 1 | 0 | |a Pediatric psychopharmacology for primary care / |c Mark A. Riddle |
| 250 | |a Third edition | ||
| 264 | 1 | |a Itasca, IL : |b American Academy of Pediatrics, |c [2022] | |
| 264 | 4 | |c ©2022 | |
| 300 | |a 1 online resource | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 588 | 0 | |a Online resource; title from resource web page (AAP eBooks, viewed on October 29, 2021) | |
| 504 | |a Includes bibliographical references and index | ||
| 505 | 0 | |a Introduction -- Part 1: Before Prescribing -- Chapter 1. Getting Started -- Chapter 2. Conceptual Framework for Prescribing Psychotropic Medications -- Chapter 3. Making a Diagnosis -- Chapter 4. Laying the Groundwork -- Part 2: Group 1 Medications for Specific Diagnoses: Attention-Deficit/Hyperactivity Disorder, Anxiety, and Depression -- Chapter 5. Group 1 Medications for Attention-Deficit/Hyperactivity Disorder -- Chapter 6. Group 1 Medications for Anxiety and Depression -- Part 3: Group 2 and Group 3 Medications -- Chapter 7. Group 2 Medications: FDA-Approved Antipsychotics and Mood Stabilizers -- Chapter 8. Group 3 Medications: Others Commonly Prescribed -- Part 4: After Prescribing: Midcourse Corrections -- Chapter 9. Fine Tuning Treatment -- Chapter 10. Managing Treatment Impasses -- Appendix A. Assessment and Symptom Monitoring Tools -- Appendix B. Resources for Clinicians -- Appendix C. Training Resources for Clinicians -- Appendix D. Quality Ratings for Psychotherapies and Efficacy Data for Medications -- Appendix E. Resources for Caregivers -- Appendix F. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Complete Criteria of Select Diagnoses. | |
| 520 | |a Completely updated and revised, the third edition provides primary care physicians with practice-tested, condition-specific treatment recommendations for various childhood mental disorders. Obtain clear guidance on dosing, monitoring, and potential adverse reactions of psychotropic medications for treatment of common psychiatric disorders and mental health or behavioral problems in children and adolescents. -- Provided by publisher. | ||
| 650 | 0 | |a Pediatric psychopharmacology. |0 http://id.loc.gov/authorities/subjects/sh85099172 | |
| 650 | 0 | |a Pediatric pharmacology. |0 http://id.loc.gov/authorities/subjects/sh85099170 | |
| 650 | 0 | |a Children. |0 http://id.loc.gov/authorities/subjects/sh85023418 | |
| 650 | 1 | 2 | |a Mental Disorders |x drug therapy |0 https://id.nlm.nih.gov/mesh/D001523Q000188 |
| 650 | 1 | 2 | |a Child |0 https://id.nlm.nih.gov/mesh/D002648 |
| 650 | 2 | 2 | |a Psychotropic Drugs |x administration & dosage |0 https://id.nlm.nih.gov/mesh/D011619Q000008 |
| 650 | 2 | 2 | |a Adolescent |0 https://id.nlm.nih.gov/mesh/D000293 |
| 650 | 6 | |a Psychopharmacologie pédiatrique. | |
| 650 | 6 | |a Pharmacologie pédiatrique. | |
| 650 | 6 | |a Enfants. | |
| 650 | 7 | |a children (people by age group) |2 aat | |
| 650 | 7 | |a Children |2 fast | |
| 650 | 7 | |a Pediatric pharmacology |2 fast | |
| 650 | 7 | |a Pediatric psychopharmacology |2 fast | |
| 655 | 4 | |a Internet Resources. | |
| 710 | 2 | |a American Academy of Pediatrics, |e issuing body. |0 http://id.loc.gov/authorities/names/n79018368 | |
| 776 | 0 | 8 | |i Print version: |a Riddle, Mark A. |t Pediatric psychopharmacology for primary care. |b Third edition. |d Elk Grove Village : American Academy of Pediatrics, 2021 |z 9781610025461 |w (DLC) 2021900633 |w (OCoLC)1268138516 |
| 856 | 4 | 0 | |l FWS01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=3042711 |3 Volltext |
| 938 | |a EBSCOhost |b EBSC |n 3042711 | ||
| 938 | |a Teton Data Systems |b STAT |n tds757 | ||
| 938 | |a YBP Library Services |b YANK |n 302473014 | ||
| 994 | |a 92 |b GEBAY | ||
| 912 | |a ZDB-4-EBA | ||
| 049 | |a DE-863 | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-4-EBA-on1269480406 |
|---|---|
| _version_ | 1816882550680846336 |
| adam_text | |
| any_adam_object | |
| author | Riddle, Mark A. |
| author_GND | http://id.loc.gov/authorities/names/no2009132554 |
| author_facet | Riddle, Mark A. |
| author_role | aut |
| author_sort | Riddle, Mark A. |
| author_variant | m a r ma mar |
| building | Verbundindex |
| bvnumber | localFWS |
| callnumber-first | R - Medicine |
| callnumber-label | RJ504 |
| callnumber-raw | RJ504.7 .R53 2022eb |
| callnumber-search | RJ504.7 .R53 2022eb |
| callnumber-sort | RJ 3504.7 R53 42022EB |
| callnumber-subject | RJ - Pediatrics |
| collection | ZDB-4-EBA |
| contents | Introduction -- Part 1: Before Prescribing -- Chapter 1. Getting Started -- Chapter 2. Conceptual Framework for Prescribing Psychotropic Medications -- Chapter 3. Making a Diagnosis -- Chapter 4. Laying the Groundwork -- Part 2: Group 1 Medications for Specific Diagnoses: Attention-Deficit/Hyperactivity Disorder, Anxiety, and Depression -- Chapter 5. Group 1 Medications for Attention-Deficit/Hyperactivity Disorder -- Chapter 6. Group 1 Medications for Anxiety and Depression -- Part 3: Group 2 and Group 3 Medications -- Chapter 7. Group 2 Medications: FDA-Approved Antipsychotics and Mood Stabilizers -- Chapter 8. Group 3 Medications: Others Commonly Prescribed -- Part 4: After Prescribing: Midcourse Corrections -- Chapter 9. Fine Tuning Treatment -- Chapter 10. Managing Treatment Impasses -- Appendix A. Assessment and Symptom Monitoring Tools -- Appendix B. Resources for Clinicians -- Appendix C. Training Resources for Clinicians -- Appendix D. Quality Ratings for Psychotherapies and Efficacy Data for Medications -- Appendix E. Resources for Caregivers -- Appendix F. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Complete Criteria of Select Diagnoses. |
| ctrlnum | (OCoLC)1269480406 |
| dewey-full | 615.7/8083 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615.7/8083 |
| dewey-search | 615.7/8083 |
| dewey-sort | 3615.7 48083 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| edition | Third edition |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04486cam a2200649 i 4500</leader><controlfield tag="001">ZDB-4-EBA-on1269480406</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr cnu---unuuu</controlfield><controlfield tag="008">210929t20222022ilu ob 001 0 eng d</controlfield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">YDX</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="e">pn</subfield><subfield code="c">YDX</subfield><subfield code="d">N$T</subfield><subfield code="d">YDX</subfield><subfield code="d">TETON</subfield><subfield code="d">CUV</subfield><subfield code="d">KOS</subfield><subfield code="d">OCLCO</subfield><subfield code="d">HF9</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCL</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">CASUM</subfield><subfield code="d">USU</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCL</subfield><subfield code="d">OCLCQ</subfield></datafield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">1269317143</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781610025478</subfield><subfield code="q">(electronic book)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1610025474</subfield><subfield code="q">(electronic book)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9781610025461</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">1610025466</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1269480406</subfield><subfield code="z">(OCoLC)1269317143</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RJ504.7</subfield><subfield code="b">.R53 2022eb</subfield></datafield><datafield tag="060" ind1=" " ind2="4"><subfield code="a">WS 350.33</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">615.7/8083</subfield><subfield code="2">23</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Riddle, Mark A.,</subfield><subfield code="e">author.</subfield><subfield code="0">http://id.loc.gov/authorities/names/no2009132554</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pediatric psychopharmacology for primary care /</subfield><subfield code="c">Mark A. Riddle</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">Third edition</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Itasca, IL :</subfield><subfield code="b">American Academy of Pediatrics,</subfield><subfield code="c">[2022]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">©2022</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Online resource; title from resource web page (AAP eBooks, viewed on October 29, 2021)</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Introduction -- Part 1: Before Prescribing -- Chapter 1. Getting Started -- Chapter 2. Conceptual Framework for Prescribing Psychotropic Medications -- Chapter 3. Making a Diagnosis -- Chapter 4. Laying the Groundwork -- Part 2: Group 1 Medications for Specific Diagnoses: Attention-Deficit/Hyperactivity Disorder, Anxiety, and Depression -- Chapter 5. Group 1 Medications for Attention-Deficit/Hyperactivity Disorder -- Chapter 6. Group 1 Medications for Anxiety and Depression -- Part 3: Group 2 and Group 3 Medications -- Chapter 7. Group 2 Medications: FDA-Approved Antipsychotics and Mood Stabilizers -- Chapter 8. Group 3 Medications: Others Commonly Prescribed -- Part 4: After Prescribing: Midcourse Corrections -- Chapter 9. Fine Tuning Treatment -- Chapter 10. Managing Treatment Impasses -- Appendix A. Assessment and Symptom Monitoring Tools -- Appendix B. Resources for Clinicians -- Appendix C. Training Resources for Clinicians -- Appendix D. Quality Ratings for Psychotherapies and Efficacy Data for Medications -- Appendix E. Resources for Caregivers -- Appendix F. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Complete Criteria of Select Diagnoses.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Completely updated and revised, the third edition provides primary care physicians with practice-tested, condition-specific treatment recommendations for various childhood mental disorders. Obtain clear guidance on dosing, monitoring, and potential adverse reactions of psychotropic medications for treatment of common psychiatric disorders and mental health or behavioral problems in children and adolescents. -- Provided by publisher.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Pediatric psychopharmacology.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85099172</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Pediatric pharmacology.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85099170</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Children.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85023418</subfield></datafield><datafield tag="650" ind1="1" ind2="2"><subfield code="a">Mental Disorders</subfield><subfield code="x">drug therapy</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D001523Q000188</subfield></datafield><datafield tag="650" ind1="1" ind2="2"><subfield code="a">Child</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D002648</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Psychotropic Drugs</subfield><subfield code="x">administration & dosage</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D011619Q000008</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Adolescent</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D000293</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Psychopharmacologie pédiatrique.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Pharmacologie pédiatrique.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Enfants.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">children (people by age group)</subfield><subfield code="2">aat</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Children</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pediatric pharmacology</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pediatric psychopharmacology</subfield><subfield code="2">fast</subfield></datafield><datafield tag="655" ind1=" " ind2="4"><subfield code="a">Internet Resources.</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">American Academy of Pediatrics,</subfield><subfield code="e">issuing body.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n79018368</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="a">Riddle, Mark A.</subfield><subfield code="t">Pediatric psychopharmacology for primary care.</subfield><subfield code="b">Third edition.</subfield><subfield code="d">Elk Grove Village : American Academy of Pediatrics, 2021</subfield><subfield code="z">9781610025461</subfield><subfield code="w">(DLC) 2021900633</subfield><subfield code="w">(OCoLC)1268138516</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=3042711</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">3042711</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Teton Data Systems</subfield><subfield code="b">STAT</subfield><subfield code="n">tds757</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">302473014</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
| genre | Internet Resources. |
| genre_facet | Internet Resources. |
| id | ZDB-4-EBA-on1269480406 |
| illustrated | Not Illustrated |
| indexdate | 2024-11-27T13:30:24Z |
| institution | BVB |
| institution_GND | http://id.loc.gov/authorities/names/n79018368 |
| isbn | 9781610025478 1610025474 |
| language | English |
| oclc_num | 1269480406 |
| open_access_boolean | |
| owner | MAIN DE-863 DE-BY-FWS |
| owner_facet | MAIN DE-863 DE-BY-FWS |
| physical | 1 online resource |
| psigel | ZDB-4-EBA |
| publishDate | 2022 |
| publishDateSearch | 2022 |
| publishDateSort | 2022 |
| publisher | American Academy of Pediatrics, |
| record_format | marc |
| spelling | Riddle, Mark A., author. http://id.loc.gov/authorities/names/no2009132554 Pediatric psychopharmacology for primary care / Mark A. Riddle Third edition Itasca, IL : American Academy of Pediatrics, [2022] ©2022 1 online resource text txt rdacontent computer c rdamedia online resource cr rdacarrier Online resource; title from resource web page (AAP eBooks, viewed on October 29, 2021) Includes bibliographical references and index Introduction -- Part 1: Before Prescribing -- Chapter 1. Getting Started -- Chapter 2. Conceptual Framework for Prescribing Psychotropic Medications -- Chapter 3. Making a Diagnosis -- Chapter 4. Laying the Groundwork -- Part 2: Group 1 Medications for Specific Diagnoses: Attention-Deficit/Hyperactivity Disorder, Anxiety, and Depression -- Chapter 5. Group 1 Medications for Attention-Deficit/Hyperactivity Disorder -- Chapter 6. Group 1 Medications for Anxiety and Depression -- Part 3: Group 2 and Group 3 Medications -- Chapter 7. Group 2 Medications: FDA-Approved Antipsychotics and Mood Stabilizers -- Chapter 8. Group 3 Medications: Others Commonly Prescribed -- Part 4: After Prescribing: Midcourse Corrections -- Chapter 9. Fine Tuning Treatment -- Chapter 10. Managing Treatment Impasses -- Appendix A. Assessment and Symptom Monitoring Tools -- Appendix B. Resources for Clinicians -- Appendix C. Training Resources for Clinicians -- Appendix D. Quality Ratings for Psychotherapies and Efficacy Data for Medications -- Appendix E. Resources for Caregivers -- Appendix F. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Complete Criteria of Select Diagnoses. Completely updated and revised, the third edition provides primary care physicians with practice-tested, condition-specific treatment recommendations for various childhood mental disorders. Obtain clear guidance on dosing, monitoring, and potential adverse reactions of psychotropic medications for treatment of common psychiatric disorders and mental health or behavioral problems in children and adolescents. -- Provided by publisher. Pediatric psychopharmacology. http://id.loc.gov/authorities/subjects/sh85099172 Pediatric pharmacology. http://id.loc.gov/authorities/subjects/sh85099170 Children. http://id.loc.gov/authorities/subjects/sh85023418 Mental Disorders drug therapy https://id.nlm.nih.gov/mesh/D001523Q000188 Child https://id.nlm.nih.gov/mesh/D002648 Psychotropic Drugs administration & dosage https://id.nlm.nih.gov/mesh/D011619Q000008 Adolescent https://id.nlm.nih.gov/mesh/D000293 Psychopharmacologie pédiatrique. Pharmacologie pédiatrique. Enfants. children (people by age group) aat Children fast Pediatric pharmacology fast Pediatric psychopharmacology fast Internet Resources. American Academy of Pediatrics, issuing body. http://id.loc.gov/authorities/names/n79018368 Print version: Riddle, Mark A. Pediatric psychopharmacology for primary care. Third edition. Elk Grove Village : American Academy of Pediatrics, 2021 9781610025461 (DLC) 2021900633 (OCoLC)1268138516 FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=3042711 Volltext |
| spellingShingle | Riddle, Mark A. Pediatric psychopharmacology for primary care / Introduction -- Part 1: Before Prescribing -- Chapter 1. Getting Started -- Chapter 2. Conceptual Framework for Prescribing Psychotropic Medications -- Chapter 3. Making a Diagnosis -- Chapter 4. Laying the Groundwork -- Part 2: Group 1 Medications for Specific Diagnoses: Attention-Deficit/Hyperactivity Disorder, Anxiety, and Depression -- Chapter 5. Group 1 Medications for Attention-Deficit/Hyperactivity Disorder -- Chapter 6. Group 1 Medications for Anxiety and Depression -- Part 3: Group 2 and Group 3 Medications -- Chapter 7. Group 2 Medications: FDA-Approved Antipsychotics and Mood Stabilizers -- Chapter 8. Group 3 Medications: Others Commonly Prescribed -- Part 4: After Prescribing: Midcourse Corrections -- Chapter 9. Fine Tuning Treatment -- Chapter 10. Managing Treatment Impasses -- Appendix A. Assessment and Symptom Monitoring Tools -- Appendix B. Resources for Clinicians -- Appendix C. Training Resources for Clinicians -- Appendix D. Quality Ratings for Psychotherapies and Efficacy Data for Medications -- Appendix E. Resources for Caregivers -- Appendix F. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Complete Criteria of Select Diagnoses. Pediatric psychopharmacology. http://id.loc.gov/authorities/subjects/sh85099172 Pediatric pharmacology. http://id.loc.gov/authorities/subjects/sh85099170 Children. http://id.loc.gov/authorities/subjects/sh85023418 Mental Disorders drug therapy https://id.nlm.nih.gov/mesh/D001523Q000188 Child https://id.nlm.nih.gov/mesh/D002648 Psychotropic Drugs administration & dosage https://id.nlm.nih.gov/mesh/D011619Q000008 Adolescent https://id.nlm.nih.gov/mesh/D000293 Psychopharmacologie pédiatrique. Pharmacologie pédiatrique. Enfants. children (people by age group) aat Children fast Pediatric pharmacology fast Pediatric psychopharmacology fast |
| subject_GND | http://id.loc.gov/authorities/subjects/sh85099172 http://id.loc.gov/authorities/subjects/sh85099170 http://id.loc.gov/authorities/subjects/sh85023418 https://id.nlm.nih.gov/mesh/D001523Q000188 https://id.nlm.nih.gov/mesh/D002648 https://id.nlm.nih.gov/mesh/D011619Q000008 https://id.nlm.nih.gov/mesh/D000293 |
| title | Pediatric psychopharmacology for primary care / |
| title_auth | Pediatric psychopharmacology for primary care / |
| title_exact_search | Pediatric psychopharmacology for primary care / |
| title_full | Pediatric psychopharmacology for primary care / Mark A. Riddle |
| title_fullStr | Pediatric psychopharmacology for primary care / Mark A. Riddle |
| title_full_unstemmed | Pediatric psychopharmacology for primary care / Mark A. Riddle |
| title_short | Pediatric psychopharmacology for primary care / |
| title_sort | pediatric psychopharmacology for primary care |
| topic | Pediatric psychopharmacology. http://id.loc.gov/authorities/subjects/sh85099172 Pediatric pharmacology. http://id.loc.gov/authorities/subjects/sh85099170 Children. http://id.loc.gov/authorities/subjects/sh85023418 Mental Disorders drug therapy https://id.nlm.nih.gov/mesh/D001523Q000188 Child https://id.nlm.nih.gov/mesh/D002648 Psychotropic Drugs administration & dosage https://id.nlm.nih.gov/mesh/D011619Q000008 Adolescent https://id.nlm.nih.gov/mesh/D000293 Psychopharmacologie pédiatrique. Pharmacologie pédiatrique. Enfants. children (people by age group) aat Children fast Pediatric pharmacology fast Pediatric psychopharmacology fast |
| topic_facet | Pediatric psychopharmacology. Pediatric pharmacology. Children. Mental Disorders drug therapy Child Psychotropic Drugs administration & dosage Adolescent Psychopharmacologie pédiatrique. Pharmacologie pédiatrique. Enfants. children (people by age group) Children Pediatric pharmacology Pediatric psychopharmacology Internet Resources. |
| url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=3042711 |
| work_keys_str_mv | AT riddlemarka pediatricpsychopharmacologyforprimarycare AT americanacademyofpediatrics pediatricpsychopharmacologyforprimarycare |